LIFECORE BIOMEDICAL INC
10-K, EX-27, 2000-09-15
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: LIFECORE BIOMEDICAL INC, 10-K, EX-23.1, 2000-09-15
Next: LIFECORE BIOMEDICAL INC, 10-K, EX-99, 2000-09-15



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE
BIOMEDICAL INC. FINANCIAL STATEMENTS FOR THE YEAR ENDED JUNE 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                       1,101,000
<SECURITIES>                                         0
<RECEIVABLES>                                5,482,000
<ALLOWANCES>                                   186,000
<INVENTORY>                                 21,658,000
<CURRENT-ASSETS>                            19,420,000
<PP&E>                                      42,334,000
<DEPRECIATION>                              11,982,000
<TOTAL-ASSETS>                              65,788,000
<CURRENT-LIABILITIES>                        3,890,000
<BONDS>                                      6,477,000
                                0
                                          0
<COMMON>                                       126,000
<OTHER-SE>                                  55,295,000
<TOTAL-LIABILITY-AND-EQUITY>                65,788,000
<SALES>                                     32,823,000
<TOTAL-REVENUES>                            32,823,000
<CGS>                                       17,618,000
<TOTAL-COSTS>                               33,585,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             876,000
<INCOME-PRETAX>                            (1,599,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,599,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,599,000)
<EPS-BASIC>                                      (.13)
<EPS-DILUTED>                                    (.13)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission